More than 100 kinds of human papilloma virus (HPV) are proven to exist. Over 30 kinds of HPV are transmitted through sexual contact. At least 19 types of HPV cause cervical cancer in girls and also trigger cancer of the vagina, vulva, penis, anus and certain kinds of neck cancer.

Lately, the U.S. Food and Medicine Government approved a vaccine named Gardasil, made by Merck & Co., for the prevention of contamination by women's health clinic four forms of HPV. Gardasil stops contamination by two cancer-causing HPV types (16 and 18 - accountable for 70% of cervical cancer in the United States) and two HPV forms that cause genital warts (6 and 11 - responsible for around 90% of the HPV-induced genital warts in the United States).

A opponent of Merck, GlaxoSmithKline, features a vaccine under evaluation by the FDA which they wish to own accepted in the near future. That vaccine, called Cervarix, prevents contamination with HPV types 16 and 18.

The FDA accepted Gardisil for use in girls and girls involving the ages of 9 and 25 who have never been exposed to HPV. The CDC's Advisory Committee on Immunization Methods recommends vaccination of girls at the ages of 11 or 12.

Equally Gardisil and Cervarix are very nearly 100% efficient contrary to the virus types they contain, but are probably useless against most of the strains they do not contain. Just how long the protective aftereffect of possibly HPV vaccine continues following inoculation is not known, but several experts believe weight to illness can last at the very least four years.

Actually although recent HPV vaccine just safeguards against a small amount of HPV forms, in the U.S. it's wise for ladies and women to be vaccinated since the chance of harm and demise from HPV infection is indeed high. The vaccine has very few negative effects, and medical specialists feel the risk of vaccination is extremely minimal in comparison to the benefit.

Though some religious leaders are opposed to vaccination because they're worried so it will inspire sexual promiscuity, that "virginity or demise" position does not have any legitimate place in a civil society. On one other hand, it generates small feeling for politicians to force women to be vaccinated considering that the professional vaccine, while really profitable to their company, is the beginning of the clear answer to global HPV prevention.

The newest HPV vaccines are clearly important medical development in controlling life-threatening viral infections, but issues remain. Only if girls are vaccinated, the HPV tank in males will soon be unaffected and the threat to the individual citizenry as a whole is unlikely to be reduced. With HPV attacks therefore large global, it is probable that other HPV strains maybe not involved in the commercial vaccines increases in volume over time, leaving also vaccinated persons susceptible.

From the perspective of worldwide disease control, the high cost of the vaccine helps it be too costly for use within developing countries. Constant research must improve the breadth of usefulness of HPV vaccines to incorporate defense against essentially all virus strains. Furthermore, in the future there could be healing vaccines to treat persons previously infected with HPV. For the time being, keep informed, stay hesitant of commercial marketing and unproved states, but take advantage of this useful improve in preventative medicine.